Weight loss medication works by intervening in the biological processes that regulate hunger, satiety, and fat storage. The most commonly used treatments in 2026 are GLP-1 receptor agonists, which mimic the action of a hormone naturally produced after eating. This article answers the most frequently asked questions about how weight loss medication works, from the substances involved to who may be medically suitable for treatment.
The most prescribed weight loss medication in the Netherlands contains active substances belonging to the class of GLP-1 receptor agonists. GLP-1 stands for glucagon-like peptide-1, a hormone that the body produces itself after a meal. Synthetic variants of this hormone mimic and enhance that effect, thereby having a measurable influence on weight regulation.
In addition to GLP-1 medication, combination preparations are also available that mimic multiple gut hormones, such as GIP (glucose-dependent insulinotropic polypeptide). These substances work together on receptors in the brain, pancreas, and gastrointestinal tract. The combined effect influences both blood sugar regulation and the feeling of satiety. Weight loss medication therefore does not work via a single mechanism, but via an interplay of hormonal signals.
Other classes of slimming drugs, such as lipase inhibitors, work on a different principle: they inhibit the absorption of fats in the intestine. These drugs are prescribed less often due to side effects and their more limited effectiveness compared to GLP-1 medication.
GLP-1 medication influences the feelings of hunger and satiety by acting directly on the central nervous system, specifically on the hypothalamus, the area of the brain that regulates appetite. The outcome is that people experience less hunger and reach a feeling of fullness earlier during a meal. This leads to a spontaneous reduction in calorie intake for many people.
Furthermore, GLP-1 medication slows gastric emptying. Food stays in the stomach for longer, which prolongs the feeling of fullness. This mechanism contributes to fewer eating occasions and smaller portions, without anyone needing to actively count calories. The combination of central and peripheral action makes GLP-1 medication more effective than treatments that only intervene at one point.
It is important to understand that these effects can vary from person to person. Not everyone experiences the same degree of appetite suppression, and the effect depends partly on the dosage and individual sensitivity to the medication.
Most people notice a change in their appetite within the first few weeks, but visible weight loss typically occurs after several weeks to months of use. The dosage is built up gradually, meaning the full effect of weight loss medication is only achieved after several months. Results vary from person to person.
In the initial phase, often the first four to eight weeks, the dosage is gradually increased to allow the body to get used to the active substance. Side effects may be most pronounced during this period. As the dosage rises, appetite continues to decrease in many people, and weight begins to fall.
Expectations should be kept realistic. Weight loss medication is not a quick fix, but a medically supervised journey that takes time. Those who notice little effect after a few weeks may not yet be on the therapeutically effective dosage.
The most common side effects of GLP-1 medication are gastrointestinal complaints, including nausea, diarrhoea, constipation, and bloating. These complaints mainly occur in the initial phase and tend to decrease in most people as the body gets used to the medication. Serious side effects are rarer, but a doctor always assesses whether its use is appropriate.
Nausea is the most reported side effect and is related to the delayed gastric emptying that the medication causes. Small, frequent meals and avoiding fatty or highly spiced dishes can help to limit these complaints. Many people find that the nausea significantly decreases after the first few weeks.
Less common side effects include headaches, fatigue, and a change in taste. In rare cases, more serious reactions can occur, such as inflammation of the pancreas. Therefore, medical supervision during the use of weight-loss medication is not an option, but a requirement.
Weight loss medication can contribute to weight loss, but it works best in combination with adjustments to diet and exercise. Medication reduces appetite and supports the process, but it does not replace healthy lifestyle habits. Those who rely solely on medication without behavioural change typically achieve less result and are more likely to regain weight after stopping.
This is not a judgment, but a biological fact. Slimming medication changes hormonal signals, but the underlying lifestyle factors, such as sleep, stress levels, diet, and exercise, continue to influence weight. When the medication is stopped without lifestyle adjustments, the original eating patterns can return.
A realistic treatment plan combines medication with awareness of eating behaviour. This doesn't have to be a radical lifestyle change, but small, achievable adjustments can significantly enhance the effect of the medication and contribute to a sustainable outcome.
Weight loss medication is not suitable for everyone. Generally, it is considered for individuals with a BMI of 30 or higher, or a BMI of 27 or higher in combination with weight-related conditions such as type 2 diabetes or high blood pressure. A doctor assesses on an individual basis whether treatment is medically appropriate, based on the person's individual circumstances and medical history.
There are also situations in which weight-loss medication is not prescribed. Pregnancy, certain thyroid conditions, a history of pancreatitis, and the use of specific other medications can be contraindications. This is precisely why a medical assessment precedes any treatment.
Age, weight, medical history and current medication all play a role in the assessment. Not everyone who wants to lose weight is eligible for weight loss medication, and that is a medical decision that cannot be made by the patient themselves.
Wellumo makes it possible to start a medically supervised online programme for people who want to explore whether weight loss medication is suitable for them. The process is handled carefully, with a BIG-registered doctor individually assessing each application. Wellumo offers:
Not everyone is eligible. A doctor decides independently whether a treatment is medically justified, based on the completed questionnaire and the individual situation. Would you like to know How Wellumo works Or do you have questions about the process? Then get in touch. contact us Start a direct intake to assess whether treatment is appropriate.
Need help or have a question?
Call us on +31 33 25 88 593
Our customer service team is happy to help, Monday to Friday.
Prefer to e-mail?
Send us a message at info@wellumo.com
1) Choose your treatment on the website.
2) Complete the medical questionnaire.
3) A BIG-registered doctor will assess your application.
4) Upon approval, the doctor writes a prescription and releases the partner pharmacy.
5) We will deliver discreetly to your home (possibly in subscription form).
A doctor who is BIG-registered in the Netherlands. You can see the BIG number on this site and check it in the BIG register.
After medical approval and release by the pharmacy, shipment is usually 1-3 working days (excluding Sundays/Holidays). Refrigerated transport or delivery restrictions may affect.
No. Prescription drugs are never supplied without medical assessment and pharmacy release.